[HTML][HTML] IgA nephropathy

JC Rodrigues, M Haas, HN Reich - Clinical Journal of the …, 2017 - journals.lww.com
IgA nephropathy (IgAN) is a leading cause of CKD and renal failure. Recent international
collaborative efforts have led to important discoveries that have improved our understanding …

[HTML][HTML] The emerging role of pathogenesis of IgA nephropathy

MY Wu, CS Chen, GT Yiang, PW Cheng… - Journal of clinical …, 2018 - mdpi.com
IgA nephropathy is an autoimmune disease induced by fthe ormation of galactose-deficient
IgA1 and anti-glycans autoantibody. A multi-hit hypothesis was promoted to explain full …

Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome

X Han, Y Xiao, Y Tang, X Zheng, M Anwar… - Clinical and Experimental …, 2019 - Springer
IgA nephropathy (IgAN) is the most common glomerulonephritis worldwide. The classic
manifestation of IgAN is episodic hematuria and proteinuria. Nephrotic syndrome (NS) is not …

Is hyperuricemia an independent prognostic factor for IgA nephropathy: a systematic review and meta-analysis of observational cohort studies

K Zhang, L Tang, S Jiang, Y Wang, Y Meng, M Wang… - Renal failure, 2022 - Taylor & Francis
Background Hyperuricemia has been reported to be correlated with IgA nephropathy (IgAN).
However, whether hyperuricemia or elevated serum uric acid (SUA) is an independent …

[HTML][HTML] The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study

H Li, F Wang, J Jia, T Yan, Y Liu, S Lin - BMC nephrology, 2022 - Springer
Objective To date, nephrotic syndrome (NS) has not been well characterized in patients with
IgA nephropathy (IgAN). Whether decline in serum albumin is an ominous sign in IgAN …

Clinical significance of massive proteinuria in primary IgA nephropathy with and without nephrotic syndrome: a single center cohort study

Y Hu, Z Huang, Q Cao, B Chen, S Xu, W Qiu, X You… - Renal …, 2023 - Taylor & Francis
Abstract Background Both primary IgA nephropathy (IgAN) with and without nephrotic
syndrome (NS) can present massive proteinuria (24-h urinary protein≥ 3.5 g/d). The clinical …

[HTML][HTML] Immune characteristics of IgA nephropathy with minimal change disease

H Li, W Lu, H Li, X Liu, X Zhang, L Xie, P Lan… - Frontiers in …, 2021 - frontiersin.org
Background: IgA nephropathy (IgAN) has a high degree of heterogeneity in clinical and
pathological features. Among all subsets of IgAN, the pathogenesis of IgAN with minimal …

Clinicopathological features, diagnosis, and treatment of IgA nephropathy with minimal change disease related to exposure to mercury-containing cosmetics: a case …

N Hong-Xin, L Shen-Heng, L Hong-Ying… - Clinical …, 2017 - search.proquest.com
Aim: Membranous nephropathy and minimal change disease (MCD) have been involved in
mercury-induced nephrotic syndrome. IgA nephropathy is not known to be a common …

Oral glucocorticoids with intravenous cyclophosphamide or oral glucocorticoids alone in the treatment of IgA nephropathy present with nephrotic syndrome and …

W Du, Z Chen, Z Fang, J Li, Q Weng… - Clinical Kidney …, 2023 - academic.oup.com
Background Few studies have evaluated the treatment of immunoglobulin A nephropathy
(IgAN) patients with nephrotic syndrome (NS) and mesangioproliferative glomerulonephritis …

Differences of clinicopathological characteristics and outcomes of IgA nephropathy patients with and without nephrotic syndrome

N Huang, J Li, Z Ai, L Guo, W Chen, Q Liu - International Urology and …, 2024 - Springer
Purpose To evaluate the differences in clinicopathological features and outcomes of IgA
nephropathy (IgAN) patients with and without nephrotic syndrome. Methods In this …